Citadel Advisors’s National Health Investors NHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $671K | Sell |
8,300
-4,600
| -36% | -$383K | ﹤0.01% | 8587 |
|
|
2025
Q4 | $985K | Buy |
12,900
+4,000
| +45% | +$307K | ﹤0.01% | 7424 |
|
|
2025
Q3 | $708K | Buy |
8,900
+300
| +3% | +$22.4K | ﹤0.01% | 8308 |
|
|
2025
Q2 | $603K | Sell |
8,600
-1,800
| -17% | -$132K | ﹤0.01% | 8191 |
|
|
2025
Q1 | $768K | Buy |
10,400
+1,900
| +22% | +$134K | ﹤0.01% | 7544 |
|
|
2024
Q4 | $589K | Buy |
8,500
+3,400
| +67% | +$259K | ﹤0.01% | 8194 |
|
|
2024
Q3 | $429K | Sell |
5,100
-5,100
| -50% | -$393K | ﹤0.01% | 8589 |
|
|
2024
Q2 | $691K | Sell |
10,200
-13,400
| -57% | -$859K | ﹤0.01% | 7379 |
|
|
2024
Q1 | $1.48M | Buy |
23,600
+11,800
| +100% | +$666K | ﹤0.01% | 6103 |
|
|
2023
Q4 | $659K | Sell |
11,800
-3,100
| -21% | -$164K | ﹤0.01% | 7519 |
|
|
2023
Q3 | $765K | Sell |
14,900
-600
| -4% | -$31.4K | ﹤0.01% | 7150 |
|
|
2023
Q2 | $813K | Buy |
15,500
+6,200
| +67% | +$320K | ﹤0.01% | 6893 |
|
|
2023
Q1 | $480K | Sell |
9,300
-2,200
| -19% | -$120K | ﹤0.01% | 8408 |
|
|
2022
Q4 | $601K | Sell |
11,500
-9,600
| -45% | -$526K | ﹤0.01% | 7861 |
|
|
2022
Q3 | $1.19M | Buy |
21,100
+13,400
| +174% | +$844K | ﹤0.01% | 6608 |
|
|
2022
Q2 | $467K | Sell |
7,700
-5,100
| -40% | -$290K | ﹤0.01% | 8796 |
|
|
2022
Q1 | $755K | Sell |
12,800
-6,800
| -35% | -$387K | ﹤0.01% | 8382 |
|
|
2021
Q4 | $1.13M | Sell |
19,600
-2,700
| -12% | -$149K | ﹤0.01% | 7664 |
|
|
2021
Q3 | $1.19M | Sell |
22,300
-28,900
| -56% | -$1.81M | ﹤0.01% | 7695 |
|
|
2021
Q2 | $3.43M | Buy |
51,200
+24,100
| +89% | +$1.68M | ﹤0.01% | 5281 |
|
|
2021
Q1 | $1.96M | Buy |
27,100
+4,300
| +19% | +$300K | ﹤0.01% | 6441 |
|
|
2020
Q4 | $1.58M | Sell |
22,800
-5,500
| -19% | -$350K | ﹤0.01% | 5874 |
|
|
2020
Q3 | $1.71M | Sell |
28,300
-1,100
| -4% | -$67.9K | ﹤0.01% | 5027 |
|
|
2020
Q2 | $1.78M | Sell |
29,400
-18,900
| -39% | -$1.04M | ﹤0.01% | 4777 |
|
|
2020
Q1 | $2.39M | Buy |
48,300
+17,900
| +59% | +$1.36M | ﹤0.01% | 3862 |
|
|
2019
Q4 | $2.48M | Buy |
30,400
+19,100
| +169% | +$1.56M | ﹤0.01% | 4076 |
|
|
2019
Q3 | $931K | Sell |
11,300
-15,200
| -57% | -$1.24M | ﹤0.01% | 5722 |
|
|
2019
Q2 | $2.07M | Sell |
26,500
-16,100
| -38% | -$1.25M | ﹤0.01% | 4457 |
|
|
2019
Q1 | $3.35M | Buy |
42,600
+12,800
| +43% | +$1.02M | ﹤0.01% | 3574 |
|
|
2018
Q4 | $2.25M | Buy |
29,800
+12,500
| +72% | +$942K | ﹤0.01% | 3964 |
|
|
2018
Q3 | $1.31M | Buy |
17,300
+5,700
| +49% | +$435K | ﹤0.01% | 5084 |
|
|
2018
Q2 | $855K | Buy |
11,600
+5,200
| +81% | +$367K | ﹤0.01% | 5486 |
|
|
2018
Q1 | $431K | Buy |
+6,400
| New | +$437K | ﹤0.01% | 6154 |
|
Other funds holding NHI
VPM
VCM
NAMI
Citadel Advisors's NHI Position: Q1 2026 in Review
Citadel Advisors increased its National Health Investors (NHI) stake by 266% in Q1 2026, buying an estimated $8.05M and bringing the position to 133,124 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3150.
Citadel Advisors first reported a position in NHI in Q2 2013 and has held it in 48 quarters since. The position peaked at $11.3M in Q4 2019. 318 funds tracked by Wall St. Rank hold NHI as of Q1 2026.
- Citadel Advisors held 133,124 shares of National Health Investors worth $10.8M as of Q1 2026.
- Citadel Advisors bought 96,706 National Health Investors shares in Q1 2026, an estimated $8.05M.
- National Health Investors made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3150 holding.
- Citadel Advisors first reported a position in National Health Investors in Q2 2013 and has held it in 48 quarters since.
- Citadel Advisors's National Health Investors position peaked at $11.3M in Q4 2019.
- 318 funds tracked by Wall St. Rank held National Health Investors as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.